Search Results 21-30 of 16746 for Proto-oncogene
(ALK), B-Raf proto-oncogene (BRAF) or ROS proto-oncogene 1 (ROS1) mutations who have not received appropriate therapies targeting these mutations and ...
Dr. Ji's team developed experimental systems that specifically target oncogenes and tumor suppressors in the cells of interest. These systems can be used to ...
Guidance for molecular targeted therapy will involve gene analysis of oncogenes and tumor suppressor genes. Results from these studies may provide the ...
Molecular characterization may include short tandem DNA repeat; STR) and oncogenic/tumor suppressor gene mutation analyses to assure that the derived models ...
The research also showed that patients with ASCL1 tumors with high levels of the RET oncogene protein did not survive as long as ASCL1 patients with low levels ...
This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the purpose of this ...
View all · Ablation therapy · Capsule endoscopy · Chemotherapy · Colon cancer surgery · Colonoscopy · Comprehensive genomic profiling · CT enterography · CT scan ...
The precision medicine study appears online in Oncogene and focuses on kidney cancer and its metastases. Recent studies of the same epigenomic fingerprint ...
July 2, 2021. Mayo Clinic study suggests patients with lung cancer be screened for MET oncogene featured image ... oncogene. Joe Dangor. July 1, 2021. Newly ...
... oncogenic gene expression. These include homozygous deletions targeting ARID family proteins and histone demethylases (for example, KDM6A), and pathogenic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.